CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Charlie Gersbach

November 17, 2023 | Duke Research Blog

Gersbach among those on Clarivate's Most Highly Cited Scientists for 2023

Gerbach is one of the most highly cited authors in Biology & Biochemistry

artistic rendering of CRISPR enhanced T-cells attacking tumor

November 9, 2023 | Pratt School of Engineering

Master Regulator of the Dark Genome Greatly Improves Cancer T-Cell Therapy

A CRISPR-based platform identified many genes that could potentially improve T-cell therapies for cancer treatment

November 2, 2023

CAGT Travel Award Winners: Mia Hamilton & Lauren Hong

  The Center for Advanced Genomic Technologies (CAGT) awarded two travel awards to current trainees. These awards will help trainees seek external opportunities to extend the scope and impact of their research by learning new methods or technologies and bring that expertise back to Duke. Travel [...]